Proposed Reduction to Medical Research Opposed by ASN

by Sheela Philomena on  February 17, 2011 at 1:17 PM General Health News
RSS Email Print This Page Comment
ASN opposes proposed cuts to National Institute of Health (NIH) budget for 2011. This reduction would limit the nation's ability to advance in medical research and improve public health.
 Proposed Reduction to Medical Research Opposed by ASN
Proposed Reduction to Medical Research Opposed by ASN
Advertisement

The American Society of Nephrology (ASN) strongly opposes the proposed $1.6 billion reduction to the NIH budget included in the continuing resolution (fiscal year 2011) being debated in the House of Representatives. The nation's longstanding commitment to better health has established the United States as a world leader in medical research and innovation. This leading position will be endangered should the 5.2 percent decrease in the NIH budget be implemented.

Advertisement
"This funding is crucial to NIH in order to advance scientific research, promote innovation, encourage new generations of investigators to pursue research vital to improving health, and preserve and create jobs," explains Joseph V. Bonventre, MD, PhD, ASN President (Brigham and Women's Hospital, Boston, MA). "This is no time to limit medical advances made through NIH funded research."

ASN strongly values funding for NIH research, which supports:
  1. Improved patient care: Research funded by NIH is critical to improved treatment of disease, including kidney disease, which afflicts 1 in 9 Americans.
  2. Economic recovery: More than 83 percent of NIH funding is spent in communities across the nation, creating jobs at more than 3,000 universities, medical schools, teaching hospitals, and other research institutions nationwide.
  3. Long-term competitiveness: NIH funding forms one of the key foundations for long-term US global competitiveness in industries such as biotechnology, medical devices, pharmaceuticals, and in academics.


Source: Eurekalert
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Clinical Trials Clinical Trials - The Past and The Future Clinical Trials - Different Phases of the trial 
Advertisement

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive